- Home
- PBYI vs WOLF Comparison
PBYI vs WOLF Comparison
Compare PBYI & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- WOLF
- Stock Information
- Founded
- PBYI 2010
- WOLF 1987
- Country
- PBYI United States
- WOLF United States
- Employees
- PBYI N/A
- WOLF N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- WOLF Semiconductors
- Sector
- PBYI Health Care
- WOLF Technology
- Exchange
- PBYI Nasdaq
- WOLF Nasdaq
- Market Cap
- PBYI 171.7M
- WOLF 200.8M
- IPO Year
- PBYI N/A
- WOLF 1993
- Fundamental
- Price
- PBYI $5.73
- WOLF $1.35
- Analyst Decision
- PBYI Strong Buy
- WOLF Hold
- Analyst Count
- PBYI 1
- WOLF 13
- Target Price
- PBYI $7.00
- WOLF $10.21
- AVG Volume (30 Days)
- PBYI 736.1K
- WOLF 20.7M
- Earning Date
- PBYI 08-07-2025
- WOLF 08-25-2025
- Dividend Yield
- PBYI N/A
- WOLF N/A
- EPS Growth
- PBYI 434.29
- WOLF N/A
- EPS
- PBYI 0.97
- WOLF N/A
- Revenue
- PBYI $238,062,000.00
- WOLF $761,300,000.00
- Revenue This Year
- PBYI N/A
- WOLF N/A
- Revenue Next Year
- PBYI N/A
- WOLF $14.42
- P/E Ratio
- PBYI $5.89
- WOLF N/A
- Revenue Growth
- PBYI 8.63
- WOLF N/A
- 52 Week Low
- PBYI $2.23
- WOLF $0.39
- 52 Week High
- PBYI $5.81
- WOLF $3.33
- Technical
- Relative Strength Index (RSI)
- PBYI 88.88
- WOLF 45.40
- Support Level
- PBYI $3.05
- WOLF $1.24
- Resistance Level
- PBYI $5.06
- WOLF $1.60
- Average True Range (ATR)
- PBYI 0.35
- WOLF 0.11
- MACD
- PBYI 0.27
- WOLF -0.03
- Stochastic Oscillator
- PBYI 97.16
- WOLF 25.00
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.